Canadian Agency for Drugs and Technologies in Health. (2017). Patient group input submissions Brexpiprazole (Rexulti) (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.): Indication : treatment of schizophrenia in adults. Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Patient Group Input Submissions Brexpiprazole (Rexulti) (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.): Indication : Treatment of Schizophrenia in Adults. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Patient Group Input Submissions Brexpiprazole (Rexulti) (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.): Indication : Treatment of Schizophrenia in Adults. Canadian Agency for Drugs and Technologies in Health, 2017.
